Evidence map›Paper›PMID 42303993›Full record

ArticleNature communications2026

Modular Scalable Synthetic Gene Circuits for Complex Functions Within Minimal Computational Layers in Human Cells.

Keren Roas, Ilanit Kovalski, Odelia Mouhadeb, Tamar Aminov, Hadas Weinstein-Marom, Lior Nissim

Abstract read
In one paragraph

Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Keren RoasDepartment of Biochemistry and Molecular Biology, Institute for Medical Research Israel-Canada, Faculty of Medicine, The Hebrew, University of Jerusalem, Jerusalem, 91120, Israel.ORCID http://orcid.org/0009-0000-0553-3939
Ilanit KovalskiDepartment of Biochemistry and Molecular Biology, Institute for Medical Research Israel-Canada, Faculty of Medicine, The Hebrew, University of Jerusalem, Jerusalem, 91120, Israel.
Odelia MouhadebDepartment of Biochemistry and Molecular Biology, Institute for Medical Research Israel-Canada, Faculty of Medicine, The Hebrew, University of Jerusalem, Jerusalem, 91120, Israel.
Tamar AminovDepartment of Biochemistry and Molecular Biology, Institute for Medical Research Israel-Canada, Faculty of Medicine, The Hebrew, University of Jerusalem, Jerusalem, 91120, Israel.
Hadas Weinstein-MaromLaboratory of Cellular Immunotherapy & Synthetic Biology, MIGAL - Galilee Research Institute, Kiryat Shmona, Israel.
Lior NissimDepartment of Biochemistry and Molecular Biology, Institute for Medical Research Israel-Canada, Faculty of Medicine, The Hebrew, University of Jerusalem, Jerusalem, 91120, Israel. lior.nissim@mail.huji.ac.il.ORCID http://orcid.org/0000-0001-6495-4741

Funding

Israel Cancer Research Fund (Israel Cancer Research Fund, Inc.) 7386541Israel Science Foundation (ISF) 1644/20
6 · The paper itself

Abstract

Engineering mammalian cells to execute complex genetic programs remains a significant challenge in synthetic biology. Synthetic gene circuits typically implement sophisticated programs through cascaded computational layers. However, these architectures require numerous orthogonal parts, increase genetic payload, and deplete cellular resources, thereby limiting functionality and scalability. ‏ ‏We present a modular design framework for engineering scalable gene circuits that execute complex functions within fewer computational layers. The platform integrates orthogonal trans-splicing-based AND gates, native-synthetic hybrid promoters for tunable regulation, and synthetic microRNAs that implement inhibitory logic. Using this approach, we engineer complex circuits, including a three-input combinatorial logic gate, a half adder, a full adder, and a dynamic 3-to-1 multiplexer with a dedicated Selector Overload Status output, generated only when both selector inputs are activated. By minimizing the number of computational layers while maintaining functionality, this strategy addresses scalability barriers in gene circuit engineering and expands applicability for biomedicine, biotechnology, and fundamental biology.

Indexed as

Gene Regulatory NetworksGenes, SyntheticGenetic EngineeringSynthetic BiologyHEK293 CellsHumansMicroRNAsPromoter Regions, GeneticMicroRNAs

Identifiers

PMID42303993
PMCPMC13439058

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.